If you didn’t make it to the European Society of Cardiology (ESC) Congress 2017 the other week, Cleveland Clinic’s Steven Nissen, MD, has got you covered. In the five-minute video below, Dr. Nissen recaps and interprets three important late-breaking trials presented at the meeting:
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
As Dr. Nissen puts it in the video: “Three trials, three different domains, three pretty interesting results.”
Further acute testing not needed if ECG and high-sensitivity troponin are negative
Scott Cameron, MD, PhD, also brings wide-ranging research interests to bear
Pioneering U.K. vascular surgeon joins Cleveland Clinic
AHA statement is first comprehensive document on perioperative stroke reduction
Recognition reflects prioritization of long-term patient outcomes
Recommendations help distinguish exercise-induced remodeling from pathology
JACC review highlights factors unique to women, ways to tailor management
Pushing the envelope in ablation of atrial fibrillation, ventricular tachycardia